See what the world's top investors are buying and saying

This article is about Baillie Gifford's take on Moderna. They admit being too optimistic during COVID, once dreaming Moderna would be a trillion-dollar company, but the stock crashed 95% from its peak. Now they're cautiously optimistic: in August 2026, Moderna's personalized cancer treatment (Intismeran) succeeded in a skin cancer trial, proving the mRNA platform works beyond vaccines. They sold half their Moderna stake (reducing position) the ne…

This report is very bullish on copper, saying structural shortages are worsening and prices will keep rising. It highlights three stocks: Talon Metals (TLO) surged 34% after drilling a very high-grade…

This piece celebrates GMO's 25-year-old 'Benchmark-Free' strategy, which ignores stock indexes and focuses purely on making money. Over 25 years, it returned 5.7% after inflation, beating the traditio…

This article says the era of low inflation is over, and retirement income needs protection. The author sees supply shocks (energy, supply chains, aging) making inflation higher and less predictable. Traditional fixed annuities, cash, and regular bonds lose purchasing power. Two key holdings: Supermarket Income REIT (rents rise with UK inflation, dividend yield over 7%) and Brazilian government inflation-linked bonds (real yield of 7%, among the h…

This article argues that rising interest rates don't always hurt stocks. Damodaran says that despite the 10-year Treasury yield climbing to 4.75% in 2026, corporate earnings grew over 11%, keeping the…

This report covers Patient Capital's fund performance and holdings for the week. The fund gained 0.64%, beating the S&P 500's 0.13%. No clear market view is given, but key stocks are highlighted: NVID…

This is about the Scottish Mortgage Investment Trust's performance last month. It's a fund that holds tech and growth companies for the long term. Its share price rose 36.4%, beating the global stock…

This analysis explains why Home Depot (HD) has been so profitable. The author is bullish, crediting its 'three-legged stool' model: low prices, wide selection, and great service that reinforce each ot…

This interview features historian Walter Mead arguing that despite internal chaos, America keeps winning through information revolution and maritime trade advantages. He says Trump turns lying and dra…

This report argues investors underweight emerging markets (EM) and should treat them as a core holding, not an afterthought. Baillie Gifford says EM makes up 60% of global GDP and two-thirds of growth, yet only 12% of the MSCI ACWI index. They note that investors' combined stake in Nvidia, Apple, and Microsoft nearly equals their entire EM exposure. The firm is optimistic about fiscally sound EM economies like China, Taiwan, and South Korea, and…

This report covers hedge fund Third Point's performance in August 2026. The fund lost 1.5% for the month and is down 0.7% year-to-date. No market commentary from the manager. Key holdings mentioned: W…

This piece covers a flurry of catalysts for junior mining companies, with the author cautiously optimistic. Barrick Gold's Reko Diq project in Pakistan is suspended after a security attack, and new ma…

This report says global supply chains are fragile, making resource scarcity a key investment theme. The fund (Baillie Gifford) is optimistic, betting on energy and materials. It highlights three holdings: Epiroc (mining equipment, like selling shovels in a gold rush), Martin Marietta (crushed stone, with a local monopoly due to high transport costs), and Freeport-McMoRan (copper mining, benefiting from surging demand for EVs and AI).

This piece argues that venture capital's obsession with growth over profit is creating fragile companies. The author warns investors to look beyond revenue and check unit economics and competitive moa…

This covers AI investor Sarah Guo's view that no single company will dominate AI. She sees computing power as the biggest bottleneck, with physical supply chain issues unlikely to resolve before 2030.…

This report says the Fed now has a 'third mandate'—managing who gets credit. Big companies borrow easily, but consumers and small businesses struggle, creating a 'K-shaped' economy. GMO is cautious, e…

This report covers the Patient Capital fund's performance for the week ending August 28. The fund was flat (0.03%), lagging the S&P 500 (0.50%), but is up 17.67% year-to-date, beating the index by 4.1…

This article is about the UK Growth Trust adding seven new stocks after appointing a new co-manager. The fund is optimistic that many UK growth companies have strong fundamentals but are undervalued by the market. Three key holdings: Marks & Spencer is turning around with better food and fashion sales; Croda, a specialty chemicals firm, is recovering from a destocking cycle; and Cranswick is investing in a new chicken plant to boost production an…

This report says global food demand will rise over 50% by 2050, but fertilizer supply is fragile (a third of seaborne fertilizer passes through the Strait of Hormuz, a geopolitical chokepoint). The author (Baillie Gifford fund) is optimistic about two companies: Deere uses precision farming tech like See & Spray, which cuts herbicide use by up to 50%, and ExactShot, which cuts fertilizer use by up to 60%; its engaged acres grew from 315 million t…

This report says governments always lose when they try to fight market forces (like capping bond yields), which benefits gold and mining stocks. The author is bullish on gold and copper, seeing trade…